151 – 160 of 376
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Management of Bleeding In Acquired Hemophilia Results of the European Acquired Hemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
Selective Persistence of Distinct Stem/B Leukaemic Stem Cells In Childhood Acute Lymphoblastic Leukaemia In Clinical Remission
(
- Contribution to journal › Published meeting abstract
-
Mark
Inhibitor Eradication In Acquired Haemophilia A Final Results of European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
W41/W41 blastocyst complementation: a system for genetic modeling of hematopoiesis.
(
- Contribution to journal › Article
-
Mark
beta(2)-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome
(
- Contribution to journal › Article
-
Mark
Cripto Selectively Expands a Distinct Population of Hematopoietic Stem Cells Expressing the Cell Surface Receptor GRP78 and Strongly Induces An Immature Phenotype In Vivo After Ex Vivo Culture
(
- Contribution to journal › Published meeting abstract
-
Mark
Human Embryonic Stem Cell Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune Modulatory Function Implications for off the Shelf ES MSC Therapies
(
- Contribution to journal › Published meeting abstract
-
Mark
Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study
(
- Contribution to journal › Published meeting abstract
-
Mark
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
(
- Contribution to journal › Article
-
Mark
Myeloid Leukemia of Down Syndrome The Results of An International Retrospective Study
(
- Contribution to journal › Published meeting abstract